Outcomes of endoscopic submucosal dissection of early gastric cancer neoplasia in the West and change in the absolute indications

Endoscopy 2024; 56(05): 390
DOI: 10.1055/a-2215-5644

Letter to the editor

Glòria Fernández-Esparrach

¹Endoscopy Unit, Gastroenterology Department, Hospital Clínic de Barcelona, University of Barcelona, IDIBAPS, CIBEREHD, Barcelona, Spain

,

²Gastroenterology Department, Hospital Universitario 12 de Octubre, Madrid, Spain

References
1 Bhandari P, Abdelrahim M, Alkandari AA. et al. Predictors of long-term outcomes of endoscopic submucosal dissection of early gastric neoplasia in the West: a multicenter study. Endoscopy 2023; 55: 898-906
2 Ngamruengphong S, Ferri L, Aihara H. et al. Efficacy of endoscopic submucosal dissection for superficial gastric neoplasia in a large cohort in North America. Clin Gastroenterol Hepatol 2021; 19: 1611-1619
3 Manta R, Galloro G, Pugliese F. et al. Endoscopic submucosal dissection of gastric neoplastic lesions: an Italian, multicenter study. J Clin Med 2020; 9: 737
4 Fernández-Esparrach G, Marín-Gabriel JC, de Tejada AH. et al. Implementation of endoscopic submucosal dissection in a country with a low incidence of gastric cancer: results from a prospective national registry. United European Gastroenterol J 2021; 9: 718-726
5 Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2021 (6th edition). Gastric Cancer 2023; 26: 1-25